Literature DB >> 19476664

[Factors associated with tuberculosis treatment non-compliance in Antananarivo city, Madagascar].

El-C Julio Rakotonirina1, Lantonirina Ravaoarisoa, Fidiniaina Mamy Randriatsarafara, Jean de Dieu Marie Rakotomanga, Annie Robert.   

Abstract

A retrospective epidemiological study of patients' medical records (n = 442) was conducted in one of the tuberculosis (TB) treatment centers in the city of Antananarivo, to identify risk factors of treatment default. Results show that males give up treatment more than women (OR=1,81 [1,13; 3,03]). Among those living farthest away from the center, patients younger than 30 years old tend to be more irregular in the follow-up of their treatment (OR=3,43 [1,16; 10,15]). There is no statistically significant relationship between TB treatment default and the patient's age, the clinical form, the therapeutic regime or the place of residence. Managers of treatment centers should be more aware and vigilant regarding male and young TB patients presenting these characteristics and should adapt methods and means for follow-up according to these risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476664     DOI: 10.3917/spub.092.0139

Source DB:  PubMed          Journal:  Sante Publique        ISSN: 0995-3914            Impact factor:   0.203


  3 in total

1.  Glucosamine/L-lactide copolymers as potential carriers for the development of a sustained rifampicin release system using Mycobacterium smegmatis as a tuberculosis model.

Authors:  Jorge Ragusa; Daniela Gonzalez; Sumin Li; Sandra Noriega; Maciej Skotak; Gustavo Larsen
Journal:  Heliyon       Date:  2019-04-28

2.  [Characteristics of TB patients in west Cameroon: 2000-2009].

Authors:  Michel Noubom; Fabrice Djouma Nembot; Hubert Donfack; Patrick Stéphane Kouomboua Mfin; Floriane Tchasse
Journal:  Pan Afr Med J       Date:  2013-10-05

3.  In vitro antimycobacterial studies of flavonols from Bauhinia vahlii Wight and Arn.

Authors:  Thanh-Trung Nguyen; Alekhya Ketha; Ho Viet Hieu; Vinay Bharadwaj Tatipamula
Journal:  3 Biotech       Date:  2021-02-16       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.